News
Millendo Raises $62M to Bring Women’s Health Therapeutics to Market
1/15/2016In January 2016, University of Michigan startup Millendo Therapeutics announced that it had raised $62 million in Series B investment. In addition, the company, which was previously know as Atterocor, announced that they had endeared into an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to...
SenSigma: Smart Optical Monitoring Systems
1/15/2016Defect formation is a highly problematic part of the manufacturing process. Every year, faulty products cause billions of dollars in material costs and production delays. U-M Mechanical Engineering and Materials Science Professor Jyoti Mazumder first became interested in online detection of defects for car body fabrication more than 12 years...
Reprogramming Brain Circuits to Alleviate the Symptoms of Tinnitus
1/15/2016An innovative treatment for a common hearing disorder… For the nearly 50 million Americans who suffer from the hearing condition tinnitus, every moment of every day is filled with unwanted noise. Whether it manifests as ringing, hissing, humming or buzzing, that non-stop sound can be disruptive and even debilitating. U-M...
Technology for the Athlete’s Toolbox: Motion Tracking for Improved Performance
1/15/2016Fourteen years ago, Professor Noel Perkins had no idea that his love of fly fishing would result in a transformative technology for sports training. At the time, he had just one goal: improve his fly casting. Frustrated with books and videos, he attached an angular-rate gyroscope to the grip of...
Changing the Future of Mobility: Advanced Transportation Innovation
1/15/2016Research partnerships and innovations from the University of Michigan and our industry partners are creating exciting advances in automobile and other forms of transportation. U-M researchers are key contributors in many areas, including electrification technologies, digital solutions (connected vehicles and mobility), advanced materials (safety and improved fuel economy) and energy...
Menin-MLL Inhibitors: A Potential Treatment for a Rare and Deadly Leukemia
1/15/2016Oncology researchers Jolanta Grembecka and Tomasz Cierpicki began what they refer to as their “adventures in drug discovery” at the University of Virginia, where they focused on treatments for leukemia-related diseases. Their ultimate goal has always been to create new small molecules for protein targets neglected by industry—what are known...
The Neuroma Surgical Tool: Advancing Treatments for Amputees
1/13/2016Each year, approximately 185,000 amputations are performed in this country. One of the biggest challenges facing amputees is constant, severe pain caused by neuromas—balls of raw nerve fiber that grow at the end of severed nerves. Research conducted by U-M Professor of Plastic Surgery Paul Cederna demonstrated that this pain...
GENOMENON: Empowering Personalized Medicine
1/13/2016Genome sequencing has revolutionized the health care field, opening the way to a new era of personalized medicine. It is now possible to sequence the entire human genome—all 3 billion letters of information— in about a day. But analyzing and interpreting the data is a slow, error-prone process that can...
Rapid Oxygen seeks to bring new emergency oxygen system to market
1/11/2016Rapid Oxygen Company wants to breathe fresh air into the stale medical oxygen systems market using technology from the University of Michigan Department of Emergency Medicine. Current supplemental oxygen systems use portable concentrators, high pressure gas cylinders, or chemical generators – technology largely unchanged since the 1940s. These “state-of-the-art” systems...
Sony launches connected tennis racket with U-M tech
12/8/2015Just months after Wilson Sporting Goods launched its Wilson X Connected Basketball employing patented technology from the University of Michigan lab of Noel Perkins, Sony, through a sub-license with Wilson, has come to market with a smart tennis sensor based on the same underlying U-M technology. The sensor, when affixed...
ONL Therapeutics: Addressing Retinal Eye Disease
10/20/2015As a clinician and an associate professor of ophthalmology in the Kellogg Eye Center, Dr. David Zacks specializes in disorders of the retina. The problem that fascinates and perplexes him most is this: Even after receiving treatment for retinal disease, patients continue to lose vision. So what are the molecular...
U-M Wireless Integrated Circuits and Systems Group: Making the Internet-of-Things Possible
10/20/2015Experts agree that the next evolutionary phase in computing technology will be the Internet of Things (IoT): tiny, self-powered, edge-of-the-cloud devices that connect people and systems. It is predicted that within 10 years as many as 1 trillion IoT connected devices will be in use—comprising a $14 trillion market. Ultimately,...